New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 24, 2013
16:00 EDTOPKOPKO citicoline products approved for commercialization in Spain
OPKO Health announced that its Barcelona, Spain subsidiary, Pharmadiet, S.L.U., received regulatory approval from Spain’s health authority for commercialization of its oral and injectable formulations of citicoline. Final marketing authorization is expected within 60 to 90 days.
News For OPK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 20, 2015
12:41 EDTOPKOPKO Health annouces publication of 20 year outcome study for prostate cancer
OPKO Health announced the online publication of a study entitled “Improving the Specificity of Screening for Lethal Prostate Cancer Using Prostate-specific Antigen and a Panel of Kallikrein Markers: A Nested Case-Control Study” in the journal European Urology. The study shows that the four kallikrein panel of biomarkers utilized in the OPKO 4Kscore Test accurately identify men more likely to develop distant prostate cancer metastases, and men with a low 4Kscore were shown to have a low risk of developing metastatic prostate cancer in a 20-year follow up period. The study is part of the Västerbotten Intervention Project, which was initiated in 1986 in Västerbotten County, Sweden, and is a population-based study involving a health exam at ages 40, 50, and 60 years of age, where blood was drawn and preserved. The VIP study included data on over 40,000 men, representing greater than 57% of the total background population in Västerbotten County. From this cohort, blood samples of men who developed metastatic prostate cancer and age-matched controls of cancer free men were tested for the four kallikreins and their 4Kscore result was determined.
February 18, 2015
11:48 EDTOPKOPKO Health management to meet with Jefferies
Subscribe for More Information
05:56 EDTOPKStocks with implied volatility above IV index mean; OPK FOSL
Subscribe for More Information
February 17, 2015
04:42 EDTOPKStocks with implied volatility above IV index mean; OPK MBI
Stocks with implied volatility above IV index mean; OPKO Health (OPK) 58, MBIA (MBI) 56 according to iVolatility.
February 12, 2015
05:51 EDTOPKStocks with implied volatility movement; OPK RIG
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use